Viewing Study NCT01735604


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-05-21 @ 4:24 PM
Study NCT ID: NCT01735604
Status: UNKNOWN
Last Update Posted: 2015-09-29
First Post: 2012-11-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy
Sponsor: Chinese PLA General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematopoietic/Lymphoid Cancer View
None Adult Acute Lymphoblastic Leukemia in Remission View
None B-cell Adult Acute Lymphoblastic Leukemia View
None B-cell Chronic Lymphocytic Leukemia View
None Prolymphocytic Leukemia View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Stage III Adult Diffuse Large Cell Lymphoma View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Grade 1 Follicular Lymphoma View
None Stage III Grade 2 Follicular Lymphoma View
None Stage III Grade 3 Follicular Lymphoma View
None Stage III Mantle Cell Lymphoma View
None Stage IV Adult Diffuse Large Cell Lymphoma View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Grade 1 Follicular Lymphoma View
None Stage IV Grade 2 Follicular Lymphoma View
None Stage IV Grade 3 Follicular Lymphoma View
None Stage IV Mantle Cell Lymphoma View
Keywords: